跳至主要内容
临床试验/NCT06968637
NCT06968637招募中不适用

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Supply Side

Orbis3 个研究点 分布在 1 个国家目标入组 336 人开始时间: 2025年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Orbis
入组人数
336
试验地点
3
主要终点
The proportion of participants reaching WHO target HbA1c levels of <= 7.0% (or WHO blood sugar targets if HbA1c data are unavailable) among participants with any DR, upon chart review by a masked clinician observer, compared between study groups.

研究概览

简要总结

The goal of this clinical trial is to determine whether integration of vision care into the DM treatment system, by providing specific recommendations to doctors for management of diabetes alongside feedback on positive eye exams for DR can improve diabetes care outcomes.

The main questions it aims to answer are:

  1. Does delivery of specific diabetes management recommendations to diabetes doctors for patients of theirs found to have DR lead to significantly improved blood glucose control as indicated by % reaching WHO targets of HbA1c (or targets for blood sugar if HbA1c data are unavailable)?
  2. What is the cost-effectiveness of the intervention, measured as total intervention cost per additional participant reaching the WHO target?

Researchers will compare participant adherence with international guidelines when DR results are provided by a PIS without specific care recommendations to when the PIS provides DR results with specific care recommendations for DM management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with DM
  • Diagnosed with DR in at least one eye
  • Over 30 years of age
  • Currently treated at the Dinajpur Diabetes Hospital and Gausul Azam BNSB Eye Hospital in Bangladesh
  • willingness to participate in the study

排除标准

  • Any ocular condition impairing the view of the fundus sufficiently to preclude grading of the image for DR.
  • Inability to comply with retinal photography to the extent that a gradable image cannot be captured, or any other factor leading to absence of sufficient images to grade at least one eye of a participant.
  • Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
  • Unwilling to participate in the study, or incapable of giving informed consent.

结局指标

主要结局

The proportion of participants reaching WHO target HbA1c levels of <= 7.0% (or WHO blood sugar targets if HbA1c data are unavailable) among participants with any DR, upon chart review by a masked clinician observer, compared between study groups.

时间窗: From enrollment to chart review (3 months after enrollment)

According to the World Health Organization (WHO), the specific HgA1c target is \<= 7.0%

次要结局

  • Cost-effectiveness, measured as total intervention cost per additional patient meeting the WHO blood sugar target.(Enrollment to chart review (3 months after enrollment))

研究者

发起方
Orbis
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验